L. Cohen

4.5k total citations · 1 hit paper
33 papers, 2.9k citations indexed

About

L. Cohen is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, L. Cohen has authored 33 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 16 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in L. Cohen's work include Virus-based gene therapy research (17 papers), CAR-T cell therapy research (5 papers) and RNA Interference and Gene Delivery (5 papers). L. Cohen is often cited by papers focused on Virus-based gene therapy research (17 papers), CAR-T cell therapy research (5 papers) and RNA Interference and Gene Delivery (5 papers). L. Cohen collaborates with scholars based in United States, Australia and Myanmar. L. Cohen's co-authors include Richard O. Snyder, Olivier Danos, Bryan E. Roberts, S Clift, Richard C. Mulligan, S. Kaye Spratt, Fray F. Marshall, Elizabeth M. Jaffee, Drew M. Pardoll and Dea Nagy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

L. Cohen

33 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

1997 504 citations Richard O. Snyder, Carol H. Miao et al. Nature Genetics profile →

Peers

Countries citing papers authored by L. Cohen

Since Specialization

Citations

This map shows the geographic impact of L. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Cohen more than expected).

Fields of papers citing papers by L. Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Cohen. The network helps show where L. Cohen may publish in the future.

Co-authorship network of co-authors of L. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of L. Cohen. A scholar is included among the top collaborators of L. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Cohen. L. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies 2000 ·Cancer Chemotherapy and Pharmacology ·William G. Nelson, Jonathan W. Simons, Bahar Mikhak, (unknown), Angelo M. De Marzo, (unknown), Michael Kim, (unknown), Angelo A. Baccala, (unknown), S Clift, Dale Ando, Hyam I. Levitsky, L. Cohen, Martin G. Sanda, Richard C. Mulligan, Alan W. Partin, H. Ballentine Carter, (unknown), Fray F. Marshall	62
2	Regulation of gene expression in vivo following transduction by two separate rAAV vectors 1998 ·Nature Biotechnology ·Katherine G. Rendahl, Stuart E. Leff, Gillis R. Otten, (unknown), Delphine Bohl, Melinda Van Roey, Brian A. Donahue, L. Cohen, Ronald J. Mandel, Olivier Danos, Richard O. Snyder	93
3	Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted within an Immunoisolation Device into Athymic Rodents 1998 ·Human Gene Therapy ·James H. Brauker, (unknown), Varavani Dwarki, Tarlochan Nijjar, Rey Chin, Victoria Carr-Brendel, (unknown), (unknown), Wendy Stone, L. Cohen, Robert C. Johnson	31
4	A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy 1997 ·Cancer Immunology Immunotherapy ·K.A.O. Ellem, Michael G. E. OʼRourke, Gregory R. Johnson, Gordon Parry, I S Misko, Christopher Schmidt, Peter G. Parsons, Scott R. Burrows, Simone Cross, (unknown), Chung‐Leung Li, JOHN R. BELL, Philip J. Dubois, Denis J. Moss, Michael F. Good, Anne Kelso, L. Cohen, Glenn Dranoff, Richard C. Mulligan	72
5	Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors breakdown → 1997 ·Nature Genetics ·Richard O. Snyder, Carol H. Miao, G. Patijn, (unknown), Olivier Danos, Dea Nagy, Allen M. Gown, Brian Winther, Leonard Meuse, L. Cohen, Arthur R. Thompson, Mark A. Kay	504
6	Practical Aspects of the Development ofex Vivoandin VivoGene Therapy for Parkinson's Disease 1997 ·Experimental Neurology ·Krzysztof S. Bankiewicz, Stuart E. Leff, Dea Nagy, (unknown), (unknown), Kaye Spratt, L. Cohen, Michele Libonati, Richard O. Snyder, Ronald J. Mandel	41
7	Retroviral Particles Produced from a Stable Human-Derived Packaging Cell Line Transduce Target Cells with Very High Efficiencies 1997 ·Human Gene Therapy ·Jennifer L. Davis, Rochelle M. Witt, Paul R. Gross, Craig A. Hokanson, (unknown), L. Cohen, Olivier Danos, S. Kaye Spratt	26
8	Efficient and Stable Adeno-Associated Virus-Mediated Transduction in the Skeletal Muscle of Adult Immunocompetent Mice 1997 ·Human Gene Therapy ·Richard O. Snyder, S. Kaye Spratt, (unknown), Delphine Bohl, (unknown), Barbara Sloan, L. Cohen, Olivier Danos	186
9	Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice. 1995 ·Proceedings of the National Academy of Sciences ·Varavani Dwarki, Paula Belloni, Tarlochan Nijjar, Jonathan D. Smith, Lizette Couto, (unknown), S Clift, A. Berns, L. Cohen	94
10	Demonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy 1994 ·The Journal of Urology ·Martin G. Sanda, (unknown), Elizabeth M. Jaffee, Jonathan I. Epstein, (unknown), L. Cohen, Glenn Dranoff, Drew M. Pardoll, Richard C. Mulligan, Jonathan W. Simons	174
11	Host range selection of vaccinia recombinants containing insertions of foreign genes into non-coding sequences 1993 ·Vaccine ·Katharine Smith, Virginia Stallard, Jack Roos, Clyde E. Hart, Nathaly Cormier, L. Cohen, Bryan E. Roberts, Lendon G. Payne	23
12	Formation of Lentivirus Particles by Mammalian Cells Infected with Recombinant Fowlpox Virus 1991 ·AIDS Research and Human Retroviruses ·(unknown), Linda Gritz, (unknown), (unknown), L. Cohen, Dennis Panicali	49
13	Utilization of DNA recombination for the two-step replacement of growth factor sequences in the vaccinia virus genome 1991 ·Journal of Virology ·Demetri D. Spyropoulos, Virginia Stallard, Bryan E. Roberts, L. Cohen	5
14	Delineation of the viral products of recombination in vaccinia virus-infected cells 1988 ·Journal of Virology ·Demetri D. Spyropoulos, Bryan E. Roberts, Dennis Panicali, L. Cohen	49
15	Identification of the DNA sequences encoding the large subunit of the mRNA-capping enzyme of vaccinia virus 1984 ·Journal of Virology ·John R. Morgan, L. Cohen, Bryan E. Roberts	76
16	Identification and mapping of polypeptides encoded by the P3HR-1 strain of Epstein-Barr virus. 1984 ·Proceedings of the National Academy of Sciences ·L. Cohen, Samuel H. Speck, Bryan E. Roberts, J L Strominger	25
17	[43] Methods utilizing cell-free protein-synthesizing systems for the identification of recombinant DNA molecules 1983 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Jacqueline S. Miller, Bruce M. Paterson, Robert P. Ricciardi, L. Cohen, Bryan E. Roberts	68
18	An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo. 1983 ·The Journal of Immunology ·C M Edson, L. Cohen, Werner Henle, Jack L. Strominger	26
19	Characterization of the three major intracytoplasmic membrane polypeptides isolated from Rhodopseudomonas sphaeroides. 1981 ·Journal of Biological Chemistry ·L. Cohen, Samuel Kaplan	16
20	Characterization of a site-specific restriction endonuclease from Rhodopseudomonas sphaeroides 1979 ·Journal of Bacteriology ·(unknown), L. Cohen, Jeffrey F. Gardner, Samuel Kaplan	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact